Background The COVID-19 pandemic, caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is of a scale not seen since the 1918 influenza pandemic. Although …

Background Concerns regarding potential neurological complications of COVID-19 are being
increasingly reported, primarily in small series. Larger studies have been limited by both …

Background Neuropsychiatric presentations of monkeypox (MPX) infection have not been
well characterised, despite evidence of nervous system involvement associated with the …

Clinicians are increasingly recognising neurological presentations occur in some patients. 1
A case series from Wuhan described associated neurological syndromes (eg,‘dizziness’ …

SARS-CoV-2 is associated with new-onset neurological and psychiatric conditions. Detailed
clinical data, including factors associated with recovery, are lacking, hampering prediction …

… Ava Easton … Varatharaj, Aravinthan and Thomas, Naomi and Ellul, Mark and Davies,
Nicholas WS and Pollak, Tom and Tenorio, EL and Sultan, Mustafa and Easton, Ava and …

… Binks SNM, Veldsman M, Easton A, et al. Residual Fatigue and Cognitive Deficits in
Patients After Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis. JAMA Neurol …

Objectives Our aim was to compare neuropsychological and psychiatric outcomes across
three encephalitis aetiological groups: Herpes simplex virus (HSV), other infections or …

In recent years, autoimmunity has been increasingly recognised as an important cause of
encephalitis. Many different antibodies are now known to target antigens on the neuronal …

Purpose The purpose of this study was to assess long-term psychosocial outcomes of anti-N-methyl-d-aspartate
(NMDA) receptor encephalitis (anti-NMDARE). Methods Adolescents …